Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation
- PMID: 20694785
- DOI: 10.1007/s11655-010-0276-8
Magnetic resonance imaging of Alzheimer's disease: from diagnosis to therapeutic evaluation
Abstract
Alzheimer's disease (AD) is a devastating late-life dementia that produces progressive loss of memory and mental faculties in elderly people. It is important to identify the earliest evidence of AD and to monitor the development of this disease for us to make positive response to its management. Magnetic resonance imaging (MRI) is powerful to image the tissue or organ without damnification. MRI can be employed to diagnose the early AD development and monitor the key biomarker development in AD. MRI may be helpful not only in diagnosing early AD, but also in evaluating its development. This article reviews the progress of MRI on the diagnosis and detection of AD, and makes comments on its therapeutic application.
Similar articles
-
Magnetic resonance imaging based clinical research in Alzheimer's disease.J Alzheimers Dis. 2012;31 Suppl 3:S5-18. doi: 10.3233/JAD-2011-111292. J Alzheimers Dis. 2012. PMID: 22233763 Review.
-
MRI and CSF studies in the early diagnosis of Alzheimer's disease.J Intern Med. 2004 Sep;256(3):205-23. doi: 10.1111/j.1365-2796.2004.01381.x. J Intern Med. 2004. PMID: 15324364
-
Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.Int J Geriatr Psychiatry. 2015 May;30(5):505-13. doi: 10.1002/gps.4173. Epub 2014 Jul 7. Int J Geriatr Psychiatry. 2015. PMID: 25043833
-
[Diagnosis without therapy: early diagnosis of Alzheimer's disease in the stage of mild cognitive impairment].Nervenarzt. 2011 Sep;82(9):1151-9. doi: 10.1007/s00115-010-3213-3. Nervenarzt. 2011. PMID: 21221517 Review. German.
-
Seven-Tesla MRI and neuroimaging biomarkers for Alzheimer's disease.Neurosurg Focus. 2015 Nov;39(5):E4. doi: 10.3171/2015.9.FOCUS15326. Neurosurg Focus. 2015. PMID: 26646928 Review.
Cited by
-
Fabrication of deferasirox-decorated aptamer-targeted superparamagnetic iron oxide nanoparticles (SPION) as a therapeutic and magnetic resonance imaging agent in cancer therapy.J Biol Inorg Chem. 2021 Feb;26(1):29-41. doi: 10.1007/s00775-020-01834-8. Epub 2020 Nov 6. J Biol Inorg Chem. 2021. PMID: 33156416
-
The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer's disease: protocol for a randomized controlled trial.Trials. 2015 Apr 30;16:199. doi: 10.1186/s13063-015-0716-z. Trials. 2015. PMID: 25925312 Free PMC article. Clinical Trial.
-
Illuminating Neural Circuits in Alzheimer's Disease.Neurosci Bull. 2021 Aug;37(8):1203-1217. doi: 10.1007/s12264-021-00716-6. Epub 2021 Jun 5. Neurosci Bull. 2021. PMID: 34089505 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical